Express Delivery
All orders are shipped with Speedy
Cash on delivery
Reliable and convenient payment methods
Proven quality
Peptides Tested at Janoshik Labs
Express delivery in 1-3 business days.
Each peptide comes with bacteriostatic water.
CJC-1295 (Mod GRF 1-29) is a synthetic analog of Growth Hormone Releasing Hormone (GHRH), composed of 29 amino acids. The modified form, known as Mod GRF 1-29, contains specific amino acid substitutions that enhance its stability and biological activity compared to the original Sermorelin. Published scientific literature describes that CJC-1295 supports the physiological release of growth hormone (GH) by stimulating the pituitary gland, intensifying natural secretion pulses. It is often considered in combination with GHRP peptides, such as Ipamorelin, due to a potential synergistic effect on GH release.
CJC-1295 (Mod GRF 1-29) is studied in relation to the following physiological processes:
Growth Hormone Stimulation – activation of GH pulses and an increase in IGF-1 have been observed in scientific models.
Influence on anabolic processes and protein synthesis.
Support for joint and bone health – effects on mineralization and recovery of tendons and bones have been described.
Regeneration and recovery – an observed role in recovery processes after physical exertion.
Sleep quality – associated with supporting deep sleep phases.
Effects on tissue regeneration – considered in relation to recovery and cell renewal processes.
Metabolic action – a connection with lipolysis and fat metabolism has been observed in research models.
In scientific literature, subcutaneous administration once daily in the range of 100–300 μg, usually in the evening before sleep, is most commonly described.
For 5 mg + 3 ml bacteriostatic water:
Concentration = 1.67 mg/ml → 0.06 ml = 100 μg
Approximate values for 5 mg:
0.06 ml = 100 μg
0.12 ml = 200 μg
0.18 ml = 300 μg
0.24 ml = 400 μg
CJC-1295 has been the subject of clinical and preclinical studies in various fields.
In endocrinology, it is considered due to its ability to increase GH and IGF-1 levels with good tolerability.
In sports medicine, interest is related to recovery, maintenance of muscle mass, and reduction of adipose tissue.
In gerontology, it is studied for its potential role in maintaining higher levels of GH and IGF-1 with advancing age.
Combining with GHRP peptides is often considered a more effective approach compared to standalone administration.
CJC-1295 is included in WADA's prohibited list for professional sports as it can:
stimulate growth hormone release
aid in muscle and tendon recovery
positively affect muscle mass and strength
participate in fat reduction processes
Reported adverse reactions in scientific literature are usually rare and mild in nature:
redness or discomfort at the injection site
fatigue
headache
mild fluid retention
Less commonly, dizziness or temporary changes in appetite may be observed.
The information is gathered and systematized from various scientific publications and studies. It serves solely for educational purposes and should not be used for the diagnosis, treatment, or prevention of diseases.